IRIS UniCatt

Siciliano, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.177
NA - Nord America 1.991
AS - Asia 789
SA - Sud America 90
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 5.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.977
DE - Germania 953
SE - Svezia 405
CN - Cina 304
SG - Singapore 272
UA - Ucraina 206
IT - Italia 168
IE - Irlanda 102
FR - Francia 95
BR - Brasile 81
GB - Regno Unito 81
FI - Finlandia 64
ID - Indonesia 59
TR - Turchia 41
IN - India 40
RU - Federazione Russa 36
BE - Belgio 22
IR - Iran 21
HK - Hong Kong 17
CA - Canada 12
CI - Costa d'Avorio 12
AT - Austria 8
EU - Europa 8
GR - Grecia 5
NL - Olanda 5
DK - Danimarca 4
IQ - Iraq 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
AU - Australia 3
BD - Bangladesh 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
JO - Giordania 3
KG - Kirghizistan 3
LT - Lituania 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
AZ - Azerbaigian 2
BY - Bielorussia 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
BG - Bulgaria 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.075
Salva come PNG Salva come JPEG
Città #
Chandler 469
Singapore 170
Ashburn 138
Jacksonville 120
San Mateo 104
Dublin 101
Ann Arbor 74
Nürnberg 62
Jakarta 58
New York 58
Wilmington 58
Cattolica 57
Nanjing 57
Boston 46
Dearborn 46
Woodbridge 39
Izmir 38
Marseille 32
Princeton 32
Redwood City 31
Helsinki 28
Beijing 27
Bremen 26
Nanchang 26
Zhengzhou 25
Moscow 24
Munich 24
Lawrence 23
Brussels 22
Houston 20
Hangzhou 19
Lancaster 19
Leawood 19
Andover 18
Augusta 18
Los Angeles 18
Hebei 17
Tianjin 17
Seattle 16
Shenyang 15
The Dalles 15
Boardman 14
Fairfield 13
Frankfurt am Main 13
Rome 13
Abidjan 12
Changsha 12
Falls Church 12
Kunming 11
Hong Kong 10
Norwalk 10
University Park 10
Milan 9
Guangzhou 8
Kish 8
Shanghai 8
Bologna 7
Jiaxing 7
London 7
Mountain View 7
Detroit 6
Jinan 6
Mcallen 6
São Paulo 6
Ardabil 5
Cambridge 5
Düsseldorf 5
Falkenstein 5
San Diego 5
Toronto 5
Vienna 5
Amsterdam 4
Athens 4
Hounslow 4
Las Vegas 4
Ningbo 4
Ottawa 4
Phoenix 4
Santa Clara 4
Zanjan 4
Amman 3
Bishkek 3
Chicago 3
Costa Mesa 3
Curitiba 3
Dubai 3
Fremont 3
Nuremberg 3
Porto Alegre 3
Portsmouth 3
Pune 3
Sacramento 3
Salvador 3
San Jose 3
Stockholm 3
Albuquerque 2
Avezzano 2
Baku 2
Bioggio 2
Brasília 2
Totale 2.567
Salva come PNG Salva come JPEG
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 223
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 189
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients 163
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 159
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 148
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 142
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 129
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 123
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 120
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 115
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 112
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 111
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 109
Microscopic colitis 108
Model for end-stage liver disease dynamic stratification of survival benefit 108
Liver transplantation in patients with alcoholic liver disease: A retrospective study 105
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 102
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 98
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 97
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 96
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 95
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 95
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 92
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 91
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 88
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 87
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 86
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 86
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 83
ANGIOTENSIN-CONVERTING ENZYME I/D POLYMORPHISM IS ASSOCIATED WITH SIGNIFICANTLY DIFFERENT VALUES OF HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH LIVER CIRRHOSIS 80
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 79
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 78
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 78
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study 78
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 75
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 73
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 71
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 70
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 69
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 68
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 68
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 67
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 67
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 66
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 65
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 65
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 61
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 59
Regorafenib: a promising treatment for hepatocellular carcinoma 58
The new era of hepatitis C treatment: still the tip of the iceberg? 55
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities] 54
Donor-Recipient MELD-Based Match in a Patient Who Required Three Liver Grafts in the Era of Nonstandard Donors: Case Report 46
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 44
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 42
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 40
Late Development of Splenic Artery Aneurysm After Orthotopic Liver Transplantation: A Case Report 38
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 37
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 35
Totale 5.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 0 0 0 0 0 0 0 76 53
2020/2021476 30 43 7 44 58 29 48 11 58 33 99 16
2021/2022598 37 55 15 39 42 18 10 120 28 38 80 116
2022/20231.201 150 160 118 202 61 171 54 95 128 7 37 18
2023/2024470 24 150 21 32 12 83 24 6 5 21 43 49
2024/2025636 16 34 84 23 111 28 25 48 149 99 19 0
Totale 5.146